24.8 C
Vientiane
Saturday, October 11, 2025
spot_img
Home Blog Page 114

TriNetX Named Among the Top 25 Healthcare Software Companies of 2025

Recognition by The Healthcare Technology Report underscores TriNetX’s innovation in real-world data, artificial intelligence, and clinical research transformation.

CAMBRIDGE, Mass., Sept. 29, 2025 /PRNewswire/ — TriNetX, the company behind the world’s broadest federated network of real-world data (RWD) and evidence, has been named one of the Top 25 Healthcare Software Companies of 2025 by The Healthcare Technology Report. This prestigious recognition celebrates TriNetX’s rapid growth, pioneering software solutions, and transformative contributions to life sciences and healthcare.

Top 25 Healthcare Software Companies 2025
Top 25 Healthcare Software Companies 2025

“This recognition reflects the vision we’ve pursued relentlessly: powering innovation across the healthcare ecosystem through data, intelligence, and technology,” said Steve Kundrot, Chief Operating Officer, TriNetX. “By bringing together a global, privacy-compliant network of real-world data with cutting-edge AI and analytics, we’re not only solving today’s clinical research challenges, but we’re also building the foundation for the next generation of precision, representativeness, and speed in drug development.”

TriNetX LIVE™, the company’s flagship platform, integrates de-identified patient data from over 300 million patients across 200+ healthcare organizations and 8,800+ sites around the world. This globally federated, privacy-compliant network fuels clinical trials with deeply enriched datasets including electronic health records (EHRs), genomics, and claims, enabling researchers to build precise patient cohorts and conduct real-time, advanced analyses.

In 2025, TriNetX continues to push boundaries by introducing next-generation features that simplify workflows, improve collaboration, and make data more intuitive to use. The platform’s forthcoming integration of large language models (LLMs) promises to transform how researchers query EHRs, making access to clinical insights as simple as asking a question.

The real-world impact of TriNetX’s technology is evident:

  • AI-driven models show promise in improving patient recruitment and enabling earlier detection in diseases like Crohn’s, pancreatic cancer, and lupus.
  • Protocol optimization tools have helped reduce costly trial amendments by up to 50%.
  • Digital waiting rooms and site intelligence are reshaping how and where clinical trials recruit patients improving representativeness, efficiency, and results.
  • TriNetX’s network has supported over 2,000 peer-reviewed publications and is actively shaping clinical practice, regulatory decisions, and global health policy.

Additional information about The Healthcare Technology Report’s Top 25 Healthcare Software Companies of 2025, including the full list of awardees, can be found on their website.

About TriNetX, LLC
TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, please visit TriNetX at www.trinetx.com or follow TriNetX on LinkedIn.

Media Contact
TriNetX
Karen Tunks
Email: Karen.Tunks@TriNetX.com

 

Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences

  • HHP and Hanmi will grant Gilead exclusive license to encequidar, and provide access to drug supply

HONG KONG, Sept. 29, 2025 /PRNewswire/ — Health Hope Pharma Limited (“HHP”) today announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. (“Gilead”) for encequidar, a first-in-class P-glycoprotein (“P-gp”) inhibitor in the field of virology.

HHP is currently exploring the potential of using encequidar to develop oral drug formulations across multiple fields. The most advanced program of HHP is oral paclitaxel combined with encequidar in the field of oncology, targeting to replace intravenous paclitaxel in chemotherapy for metastatic breast cancer. HHP targets to recruit the first patients for its global phase III clinical study for sites in the U.S. and Hong Kong SAR, respectively, by the fourth quarter of 2025.

Under the agreement, HHP and Hanmi Pharm (“Hanmi”) will grant Gilead exclusive global rights to encequidar within the field of virology. In addition, HHP and Hanmi will provide drug supply, share technical know-how, and participate as key project partners. HHP and Hanmi will each receive an upfront payment and are eligible to receive development, regulatory and sales milestones in addition to low single-digit royalties on net sales.

Prof. Dennis Lam, founder of HHP said: “We are pleased to announce the licensing agreement with Gilead and Hanmi. This demonstrates the potential of encequidar as a first-in-class P-gp inhibitor to create more oral formulations in multiple fields. This agreement is also a milestone of successful innovation for both the Hong Kong biotech industry and HHP as a biotech company headquartered in Hong Kong. We will build on this momentum to accelerate HHP’s development of oral paclitaxel combined with encequidar and explore other applications of encequidar in oral formulations.”

Jae-Hyun Park, CEO of Hanmi said: “This agreement validates Hanmi’s formulation technology and R&D capabilities, while also opening the door to new growth opportunities through collaboration with a leading global partner. We will continue to expand strategic partnerships that can accelerate innovation and patient access worldwide.”

HHP is preparing for the commencement of global clinical trials of oral paclitaxel combined with encequidar in the U.S., Hong Kong SAR, and New Zealand, with plans to launch the product in Europe, Asia, and the U.S.

About Health Hope Pharma

Health Hope Pharma is a clinical-stage oncology biopharma headquartered in HK SAR and with operations in the U.S. and the U.K., dedicated to developing novel oral anti-cancer drugs towards a safer and more convenient alternative to conventional intravenous therapy. Our flagship drug, oral paclitaxel combined with encequidar, aims to replace the widely used intravenous paclitaxel with its oral equivalent and improve the quality of life of patients.

About Hanmi Pharm

Hanmi Pharm is an R&D-focused pharmaceutical company committed to developing globally innovative therapies in areas of high unmet medical needs such as obesity/metabolism, oncology, and rare diseases. Hanmi leverages proprietary platform technologies, including long-acting biologics and bispecific antibodies, to address unmet medical needs. The company emphasizes open innovation and has established numerous global partnerships to advance its research and development efforts.

Media Relations & Investor Relations
contact@healthhopepharma.com

The Laughing Cow Wins Big: Bel Group Strengthens Regional Presence with Multiple Awards Across Southeast Asia

JAKARTA, Indonesia, Sept. 29, 2025 /PRNewswire/ — Bel Group, a global leader in branded cheese and healthy snacking, has deepened its bond with consumers across Southeast Asia, with The Laughing Cow earning multiple distinguished awards in 2025 that celebrate both trust and innovation. The accolades highlight the brand’s growing influence among families and its excellence in quality and consumer engagement across the region.

The Laughing Cow Wins Big: Bel Group Strengthens Regional Presence with Multiple Awards Across Southeast Asia
The Laughing Cow Wins Big: Bel Group Strengthens Regional Presence with Multiple Awards Across Southeast Asia

The recognitions include Parents’ Choice Awards 2025 (Malaysia)Best Cheese Brand for Families; BabyTalk + MamaPapa Readers’ Choice Awards 2025 (Malaysia)Best Cheese Wedges for Kids; Asia Excellence Awards 2025Best Digital Marketing Campaign for The Laughing Cow South East Asia and Asia Excellence Awards 2025Best Food & Grocery Brand of the Year (Dairy Products) for The Laughing Cow Creamy Cheese Triangles, South East Asia.

With consumer-voted awards in Malaysia and regional industry recognition across Southeast Asia, The Laughing Cow continues to reinforce its role as a trusted household brand, combining its rich legacy with modern relevance. “These awards not only reflect the trust and love families have for The Laughing Cow, but also the dedication of our teams across the region,” said Alamjit Singh Sekhon, General Manager, Bel South East Asia. “Guided by Bel’s global philosophy of providing accessible, nutritious, and enjoyable food ‘for all, for good,’ we are inspired to keep innovating and growing with purpose in Southeast Asia.”

The Laughing Cow has always upheld a commitment to both nutrition and local values. With a century-long legacy of bringing nutritious, enjoyable products to families globally, Bel Group maintains rigorous quality and safety standards. Two portions of The Laughing Cow Creamy Cheese Triangles provide the same amount of calcium as one glass of milk (170 ml) (Source: HealthHub Singapore). The brand in Southeast Asia only uses high-quality dairy ingredients, with no vegetable oil, no added preservatives, and no artificial colours, making it a protein- and calcium-rich snack that is both nutritious and accessible for children and families.

Bel’s iconic portfolio includes The Laughing Cow Creamy Cheese Triangles, Belcube, Cheez Dippers, and other popular Bel brands such as Babybel and Kiri. These products are available at leading supermarkets, hypermarkets, stores, as well as popular e-commerce platforms, along with your neighbourhood mom-and-pop stores in Southeast Asia.

As Bel continues its journey in Southeast Asia, its vision remains clear: to shape the future of healthy snacking while making food joyful, inclusive, and sustainable for all, for good.

About Bel 

The Bel Group stands as one of the global leaders in branded cheese and healthy snacking. With a diverse portfolio, including The Laughing Cow, Kiri, Babybel, Boursin, Nurishh, Pom’Potes, GoGo squeeZ, and other local brands, they achieved €3.6 billion in sales in 2023. Committed to providing healthier and more responsible food for all, the group boasts 10,902 employees across 30 production sites, distributing its products to nearly 120 countries.

The Laughing Cow Cheese has a rich legacy spanning over a century, promoting happiness and laughter among children and families with its nutritious range of cheese products, adding a daily dose of joy.

 

Plasmatreat GmbH: Plasma Technology Supports the Automotive Industry in Terms of Quality and Sustainability

STEINHAGEN, Germany, Sept. 29, 2025 /PRNewswire/ — The industry is facing major challenges, such as new materials, lightweight construction concepts, and growing sustainability requirements, which call for innovative manufacturing processes. Plasma technology plays a key role in meeting these challenges.

Activation of an automotive dashboard before lamination. (Copyright: Plasmatreat GmbH)
Activation of an automotive dashboard before lamination. (Copyright: Plasmatreat GmbH)

Plasmatreat GmbH develops customized applications for this purpose. The Openair-Plasma® process gently and environmentally friendly pretreats surfaces. This allows materials such as plastic, metal, and glass to be precisely cleaned and prepared for further processing. This significantly improves the adhesion of adhesives, paints, coatings and sealants without using environmentally harmful chemicals.

Additionally, these processes are dry, fully automatable, and can be integrated directly into existing production lines. This increases efficiency, reduces waste, and lowers costs. At the same time, durable bonds contribute to higher product quality and longer component life.

What exactly is plasma?

Often referred to as the “fourth state of matter,” plasma joins solid, liquid, and gaseous states. It is a high-energy gas that modifies surfaces specifically. At Plasmatreat, this modification is done in a controlled and precise manner using special nozzles. The treatment takes only seconds and immediately prepares surfaces for further processing.

Practical examples:

Plasma technology has already established itself in numerous areas of automotive production.

  • Headlights: Treating plastic parts ensures permanent adhesion and protects against moisture.
  • Interior: Pretreated surfaces allow for precise, solvent-free processing of dashboards and door modules.
  • Batteries: In electromobility, plasma improves thermal conductivity in bonded cells, resulting in shorter charging times.

Potential for Other Industries

In addition to the automotive industry, other industries benefit from plasma applications, including electronics manufacturing, medical technology, and the packaging industry. Plasma opens up new possibilities wherever reliable adhesion, clean surfaces, and environmentally friendly processes are required.

Technology for Tomorrow’s Mobility

Plasma applications are important for quality, efficiency, and sustainability in vehicle production. They support the use of modern materials and are therefore a building block for the mobility of the future.

Those interested in learning more about plasma applications will have the opportunity to do so at the K trade fair in Düsseldorf in October (Hall 11, Booth I65).

www.plasmatreat.com

 

Openair-Plasma® treatment enables chemical- and primer-free bonding, painting, printing and sealing and is already established in many processes in the automotive industry.(Copyright: Plasmatreat GmbH)
Openair-Plasma® treatment enables chemical- and primer-free bonding, painting, printing and sealing and is already established in many processes in the automotive industry.(Copyright: Plasmatreat GmbH)

 

 

CeraVe and L’Oréal Groupe Win Prestigious IFSCC Applied Research Award for Breakthrough Dandruff Study

New findings reveal critical microbial drivers, ethnic variations, and new pathways for personalized scalp care

NEW YORK, Sept. 29, 2025 /PRNewswire/ — CeraVe and L’Oréal Groupe today announced that their collaborative study on scalp biology has received the Applied Research Award at the 35th International Federation of Societies of Cosmetic Chemists (IFSCC) Congress, recognizing a breakthrough in understanding dandruff and advancing scalp barrier science.

“Receiving the IFSCC Applied Research Award is a testament to our joint commitment to scientific innovation and understanding the intricate biology of skin and scalp barrier health,” said Gene Colón, Global Senior Vice President, Medical Affairs & Communications for CeraVe at L’Oréal. “This game-changing research moves beyond the traditional view of dandruff to highlight the role of ceramide deficiency and scalp barrier dysfunction, the critical bacterial component and the impact of ethnicity. It significantly expands our scientific understanding, rooted in our foundational ceramide science, offering new perspectives and possibilities for future innovations.”

This award-winning research – the first scalp study of its kind – compared dandruff-affected and healthy scalps, assessing clinical symptoms, ceramide profiles, microbiome composition, and inflammatory markers to provide the most comprehensive picture of dandruff pathophysiology to date. Researchers from L’Oréal evaluated over 200 participants from diverse racial and ethnic backgrounds.

“This recognition reflects L’Oréal’s Research & Innovation teams’ leadership in scientific innovation and our mission to pioneer skin, hair, and scalp science continuously,” said Qian Zheng, Ph.D., Senior Vice President of Advanced Research for North America and Global Head for Regenerative Beauty at L’Oréal Groupe. “By integrating microbiome research with barrier biology through an inclusive lens, our teams are pioneering new approaches to scalp care – translating deep biological insights into targeted, effective solutions for consumers around the world.”

Importantly, this new and previously unpublished study builds on earlier microbiome research, which was published in the Journal of Drugs in Dermatology, while significantly expanding its scope. Whereas previous work characterized the scalp microbiome in a global population, the IFSCC-recognized study goes further — providing a deeper analysis by examining differences across ethnic groups and, for the first time, exploring the functional profile of the microbiome. These new dimensions — combined with insights into microbial targets beyond Malassezia (a naturally occurring fungus on the scalp that has long been associated with dandruff) and their connection to inflammation — represent a major advance in understanding dandruff biology. Key discoveries include:

  • Bacterial drivers: Staphylococcus aureus (S. aureus) and Staphylococcus capitis (S. capitis) — two types of bacteria commonly found on the skin — were consistently more abundant in dandruff across all ethnicities.
  • Strong S. aureus link: A significant positive correlation was identified between S. aureus abundance and dandruff presence and severity.
  • Virulence factors: Dandruff scalps showed significantly higher virulence factor (VF) gene levels, particularly in Latin/Hispanic and Asian American groups, with many VFs previously linked to S. aureus pathogenicity.
  • Personalized treatment: This is the first study to characterize dandruff scalp microbiome function across ethnicities, underscoring the need for diverse, personalized treatment approaches.
  • Ethnic variations: Malassezia levels were higher in dandruff across all ethnic groups except Asian Americans, and Malassezia globosa, one of the most prevalent species associated with scalp health, was prevalent on healthy scalps in all populations.

The IFSCC Congress, held annually and recognized as the most international prestigious global events in cosmetic science, brings together leading stakeholders to showcase cutting-edge scientific advancements.

About CeraVe 
Founded in 2005 with a mission to provide therapeutic skincare for all, CeraVe creates products developed with dermatologists to restore and maintain the skin’s natural barrier. All CeraVe formulas are enriched with three skin-identical ceramides (ceramides 1, 3, and 6-II), with select products featuring MVE Technology for controlled, long-lasting hydration. CeraVe is the #1 dermatologist-recommended skincare brand in the US1 and is recommended by over 90,000 dermatologists worldwide2. It is now available in over 100 countries across the globe. For more information, visit the brand on Facebook (@ceraveusa), Instagram (@cerave), TikTok (@cerave), X (@cerave), or visit www.cerave.com.

1IQVIA, ProVoice Survey, rolling 12-month data as of February 2025
2Survey conducted among the dermocosmetic market carried out by APLUSA and other partners between January 2025 and May 2025, involving dermatologists in 29 countries.

About L’Oréal
For 115 years, L’Oréal, the world’s leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as essential, inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 37 international brands and ambitious sustainability commitments in our L’Oréal for the Future program, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.

With more than 90,000 committed employees, a balanced geographical footprint and sales across all distribution networks (ecommerce, mass market, department stores, pharmacies, perfumeries, hair salons, branded and travel retail), in 2024 the Group generated sales amounting to 43.48 billion euros. With 21 research centers across 13 countries around the world and a dedicated Research and Innovation team of over 4,000 scientists and 8,000 Digital talents, L’Oréal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse.

In 2025, L’Oréal Groupe has been named the most innovative company in Europe by Fortune magazine, out of 300 companies, in a ranking spanning 21 countries and 16 industries in Europe.

More information on https://www.loreal.com/en/mediaroom

Media Contacts:
CeraVe: Christine Alkhawamchristine.alkhawam@loreal.com
Coyne PR: cerave@coynepr.com

SLiquid to Debut Southeast Asia-Specific Liquid Cooling CDU at DATA CENTRE WORLD ASIA


SINGAPORE – Media OutReach Newswire – 29 September 2025 – From October 8 to 9, SLiquid Global DataCenter (Singapore) PTE. LTD. (hereinafter referred to as “SLiquid”), an innovative practitioner in the liquid cooling industry, will participate in DATA CENTRE WORLD ASIA—the largest data center event in the region. At the exhibition, SLiquid will unveil its first liquid cooling CDU (Coolant Distribution Unit) specifically designed for the Southeast Asian market.

As data centers in Southeast Asia continue to expand rapidly, they are also facing a range of complex challenges. On the cooling front, surging demand for computing power has pushed up chip heat output, and coupled with the region’s tropical heat, traditional air cooling systems are reaching their performance limits. In terms of energy efficiency and sustainable development, countries like Singapore have introduced stringent PUE (Power Usage Effectiveness) regulations. Meanwhile, the high energy consumption of conventional cooling systems is driving up operational costs, putting data centers under dual pressure from policy compliance and cost control.

In addition, further development of data centers is also constrained by challenges including limited data hall space, increased operational complexity, reduced flexibility for scaling, and demands for higher operational stability.

Against this backdrop, liquid cooling is emerging as a breakthrough technology. Compared to traditional air cooling, liquid cooling offers significantly higher thermal efficiency, better energy consumption control, and longer hardware lifespan. Industry insiders reveal that SLiquid’s upcoming CDU product is designed with ultra-high energy efficiency, high-density and flexible scalability, robust reliability, and simplified maintenance — making it well-positioned to address the specific needs of the Southeast Asian market.

Headquartered in Singapore, SLiquid is a liquid cooling company founded on the profound industry experience of its team. The company has established three core pillars of capability: end-to-end service, liquid cooling and thermal management solutions, and comprehensive regional operations and maintenance.

With teams and operations across Singapore, Malaysia, and Qingdao, SLiquid has built an efficient and collaborative system covering R&D, manufacturing, and delivery. This setup enables faster response times and greater cost efficiency, while also offering scalable and replicable liquid cooling solutions to support the green transformation of data centers across the region.

Hashtag: #SLiquid

The issuer is solely responsible for the content of this announcement.

Applications Now Open for the 7th Guangzhou Award

SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ — On September 29, the launch ceremony of the 7th Guangzhou International Award for Urban Innovation (Guangzhou Award) took place in Seoul, South Korea, during the Metropolis Board of Directors Meeting, a key event marking Metropolis’ 40th anniversary. Mr. Hu Hao, Vice Mayor of Guangzhou, Mr. Jordi Vaquer, Secretary-General of Metropolis, and Ms. Emilia Saiz, Secretary-General of UCLG, attended and delivered speeches.

On behalf of the Guangzhou Municipal Government, Mr. Hu Hao announced the opening of the 7th Guangzhou Award. Through six previous editions, the Award has attracted participation from cities and local governments in over 100 countries and regions, offering valuable insights into enhancing urban governance capabilities. As the initiator and promoter of the Award, Guangzhou sincerely invites cities around the world to participate, share innovative governance solutions, and contribute wisdom and strength to building an open, inclusive, and sustainable community with a shared future for humankind.

Mr. Vaquer and Ms. Saiz acknowledged the role of the Guangzhou Award in promoting global urban innovation and mutual learning, and reviewed the Guangzhou Award’s efforts and achievements in fostering cooperation and sustainable development among cities worldwide. They stated that the Award has become a vital platform for showcasing local governance experiences and advancing global sustainable agendas. They encouraged more cities to submit their initiatives to jointly address global challenges such as climate change, social equity, and inclusive development, and to build more sustainable, resilient cities for the future.

During the ceremony, representatives from Guangzhou, UCLG, Metropolis, and the Chinese People’s Association for Friendship with Foreign Countries joined the stage. The event culminated as the distinguished guests jointly unrolled a scroll symbolizing the global call for submissions, officially marking the launch of the 7th Guangzhou Award.

The Guangzhou Award was jointly established in 2012 by the City of Guangzhou, UCLG, and Metropolis. Its aim is to promote sustainable urban development and international cooperation by recognizing and disseminating innovative practices in urban governance. To date, six editions have been held, attracting over 1,600 initiatives worldwide. The Award has become a global platform for the exchange and sharing of advanced urban governance experiences.

Please visit the website to learn more about the detailed guidelines and follow the updates:
https://www.guangzhouaward.org/p/the7th?lang=en

Hyundai Mobis Partners with Over 20 Companies to Foster the K-Automotive Semiconductor

  • Aiming to strengthen the private-sector-led domestic automotive semiconductor ecosystem, expanding interdisciplinary cooperation across foundries, fabless companies, packaging companies, and more
  • The company hosted the inaugural Auto Semicon Korea with the goal to localize automotive semiconductors and create a self-sustaining domestic value chain and business opportunities
  • Expected to create new growth engines in the mobility sector and build a stable supply chain by securing independent semiconductor development capabilities and production capacity

SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ — To strengthen automotive semiconductor competitiveness and expand the ecosystem in Korea, Hyundai Mobis(KRX 012330) is leading a collaboration of over 20 companies and research institutions. This marks the first private-sector-led ‘K-automotive semiconductor’ cooperation, expected to contribute to domestic automotive semiconductor industry development alongside core semiconductor localization.

'Auto Semicon Korea' by Hyundai Mobis
‘Auto Semicon Korea’ by Hyundai Mobis

Hyundai Mobis announced that it held the first ‘Auto Semicon Korea’ (ASK) on 29 at DoubleTree by Hilton Seoul Pangyo, Korea, attended by 23 companies and research institutions, including automakers, fabless companies, foundries, design houses, packaging companies, and design tool specialists.

The event was attended by Hyundai Mobis President Lee Gyu-suk, along with numerous C-suite executives and relevant officers from major companies, including Samsung Electronics, LX Semicon, SK keyfoundry, DB HiTek, GlobalFoundries, Dongwoon Anatech, and Korea Electrotechnology Research Institute (KERI)

This marks the first joint initiative led by private companies, including Hyundai Mobis, to address the automotive semiconductor industry. Until now, the automotive semiconductor sector has been heavily reliant on foreign products from Europe, North America, and Japan. Korean companies have now united to form a self-sustaining value chain and create new business opportunities to improve this situation.

Hyundai Mobis plans to play a leading role in fostering the Korean automotive semiconductor industry alongside the major companies participating in the forum. As a global Tier 1 automotive supplier, Hyundai Mobis occupies a strategic position connecting technology and demand between automakers and semiconductor suppliers. Furthermore, the company is simultaneously a fabless company designing semiconductors and a supply chain manager, positioning it as a prime candidate to lead the domestic semiconductor industry.

The event commenced with a welcome address by Hyundai Mobis President Lee Gyu-suk, followed by presentations and discussions on various topics including ‘The Necessity of Establishing a Korean Automotive Semiconductor Ecosystem’, ‘Strategies for Localizing Core Mobility Semiconductors’, and ‘Technical Direction for Building a Collaborative Framework’.

“We are securing independent semiconductor design capabilities while pursuing joint development with fabless companies and design houses, and expanding cooperation with major foundries. We actively encourage companies specialized in home appliances or mobile to enter the mobility sector, and through this, we will take the lead in building the domestic ecosystem,” Lee said.

Hyundai Mobis plans to play a pivotal role in developing ASK into Korea’s leading automotive semiconductor forum starting this year. The forum will be held annually, and starting next year, participation will be encouraged from startups and existing companies possessing semiconductor-related technologies. The forum will also open its doors to relevant associations and major institutions.

  • Planning to build a supply chain satisfying both demand companies and suppliers simultaneously also giving an advantage in the race for R&D speed

Park Chul-hong, Executive Vice President and Head of the Semiconductor Business at Hyundai Mobis, emphasized the importance of synergy between automotive semiconductors and controllers, stating, “The key to automotive semiconductors lies in optimal integration with the controller.” He added, “To enhance the differentiated competitiveness of domestic companies, Hyundai Mobis defines controller-specific specifications and supports real-vehicle-based validation, enabling significantly faster development cycles.”

In fact, Hyundai Mobis projected that for drive systems, which determine electric vehicle range, pursuing integrated development rather than developing power semiconductors and core components separately could shorten the development time by up to nearly two years. This raises expectations that partners newly entering the automotive semiconductor field alongside Hyundai Mobis will be able to achieve results quickly.

The same applies to system semiconductors installed in controllers for core components. Hyundai Mobis is mass-producing a total of 16 types of semiconductors it developed in-house this year, including power, drive, communication, sensor, and data processing semiconductors, through external foundries. The volume reaches 20 million units. Analysis suggests that the more domestic companies participate, the faster results can be achieved in semiconductor localization, with significant economic ripple effects.

Hyundai Mobis plans to leverage this forum to actively support semiconductor companies with strengths in consumer sectors like mobile as they enter the mobility field in the short term. In fact, Hyundai Mobis’ semiconductor R&D process recently obtained the international ISO 26262 certification. The company intends to share its accumulated R&D expertise—gained throughout the entire process from design to quality management—with partners, thereby contributing to enhancing the competitiveness of domestic companies.

Among the companies participating in ASK, GlobalFoundries and Dongwoon Anatech recently completed joint development with Hyundai Mobis and are poised to begin mass production of next-generation lamps and power semiconductors. These companies, specialized fabless semiconductor companies in TV and mobile sectors respectively, are seen as examples of expanding their footprint into automotive semiconductors by partnering with Hyundai Mobis.

Meanwhile, according to a global market research firm, the automotive semiconductor market is growing rapidly at an average annual rate of 9%. This market is projected to grow to approximately $135 billion (about 188 trillion won) by 2030. Within this, Hyundai Mobis’ key order items—semiconductors for infotainment and connectivity, advanced driver assistance systems (ADAS), and electrification—are expected to account for about 70% of the total market.

About Hyundai Mobis

Hyundai Mobis is the global no. 6 automotive supplier, headquartered in Seoul, Korea. Hyundai Mobis has outstanding expertise in sensors, sensor fusion in ECUs and software development for safety control. The company’s products also include various components for electrification, brakes, chassis and suspension, steering, airbags, lighting, and automotive electronics. Hyundai Mobis operates its R&D headquarters in Korea, with four technology centers in the United States, Germany, China, and India. For more information, please visit the website at http://www.mobis.com

Media Contact 
Choon Kee Hwangckhwang@mobis.com 
Jihyun Han : jihyun.han@mobis.com